Hypothalamic dopamine signaling regulates brown fat thermogenesis.


Journal

Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592

Informations de publication

Date de publication:
08 2019
Historique:
entrez: 4 10 2019
pubmed: 4 10 2019
medline: 4 10 2019
Statut: ppublish

Résumé

Dopamine signaling is a crucial part of the brain reward system and can affect feeding behavior. Dopamine receptors are also expressed in the hypothalamus, which is known to control energy metabolism in peripheral tissues. Here we show that pharmacological or chemogenetic stimulation of dopamine receptor 2 (D2R) expressing cells in the lateral hypothalamic area (LHA) and the zona incerta (ZI) decreases body weight and stimulates brown fat activity in rodents in a feeding-independent manner. LHA/ZI D2R stimulation requires an intact sympathetic nervous system and orexin system to exert its action and involves inhibition of PI3K in the LHA/ZI. We further demonstrate that, as early as 3 months after onset of treatment, patients treated with the D2R agonist cabergoline experience an increase in energy expenditure that persists for one year, leading to total body weight and fat loss through a prolactin-independent mechanism. Our results may provide a mechanistic explanation for how clinically used D2R agonists act in the CNS to regulate energy balance.

Identifiants

pubmed: 31579887
doi: 10.1038/s42255-019-0099-7
pmc: PMC6774781
mid: EMS84394
doi:

Substances chimiques

Bromocriptine 3A64E3G5ZO
Dopamine VTD58H1Z2X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

811-829

Subventions

Organisme : European Research Council
ID : 810331
Pays : International

Déclaration de conflit d'intérêts

The authors declare no conflict of interests.

Références

Nat Med. 2013 Jun;19(6):766-72
pubmed: 23685839
Nature. 1996 Aug 15;382(6592):622-6
pubmed: 8757131
Eur J Pharmacol. 2018 Jan 5;818:43-49
pubmed: 29056523
Endocrine. 2013 Aug;44(1):193-9
pubmed: 23233277
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):E1631-40
pubmed: 23569242
Obesity (Silver Spring). 2013 Dec;21(12):2513-21
pubmed: 23512420
J Neurosci. 2009 May 6;29(18):5916-25
pubmed: 19420258
J Neuroendocrinol. 2015 Apr;27(4):293-302
pubmed: 25702569
Trends Cogn Sci. 2011 Jan;15(1):37-46
pubmed: 21109477
Hippocampus. 2012 Dec;22(12):2199-207
pubmed: 22777829
Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):11383-8
pubmed: 26305972
J Mol Biol. 2009 Jun 12;389(3):480-94
pubmed: 19376132
Trends Cogn Sci. 2017 May;21(5):372-384
pubmed: 28372879
Expert Opin Ther Targets. 2002 Oct;6(5):601-9
pubmed: 12387683
Nutrition. 2000 Oct;16(10):843-57
pubmed: 11054589
Lancet Psychiatry. 2015 May;2(5):452-464
pubmed: 26360288
Cell Metab. 2017 Jul 5;26(1):212-229.e12
pubmed: 28683288
WormBook. 2013 Jul 09;:1-54
pubmed: 23908055
Prim Care Diabetes. 2016 Feb;10(1):60-5
pubmed: 26670921
J Mol Endocrinol. 2017 Feb;58(2):57-66
pubmed: 27923872
Endocrinology. 2005 Jun;146(6):2744-8
pubmed: 15746258
Endocrinology. 2016 Jul;157(7):2735-49
pubmed: 27183316
Am J Physiol Regul Integr Comp Physiol. 2002 Oct;283(4):R905-10
pubmed: 12228060
J Neurosci. 2011 Nov 2;31(44):15944-55
pubmed: 22049437
Experientia. 1992 Mar 15;48(3):248-53
pubmed: 1547854
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10493-10498
pubmed: 30254156
Surgery. 1993 Aug;114(2):400-5; discussion 405-6
pubmed: 8342141
Neuropsychopharmacology. 2011 Nov;36(12):2561-70
pubmed: 21814187
Front Behav Neurosci. 2016 Apr 12;10:66
pubmed: 27147989
J Clin Epidemiol. 1999 Mar;52(3):229-35
pubmed: 10210240
Neuropharmacology. 2013 Sep;72:197-203
pubmed: 23643747
Brain Res Bull. 1995;36(5):487-90
pubmed: 7712212
Nat Neurosci. 2014 Feb;17(2):248-53
pubmed: 24441680
Am J Physiol Regul Integr Comp Physiol. 2011 Sep;301(3):R572-80
pubmed: 21697524
Indian J Psychol Med. 2013 Apr;35(2):121-6
pubmed: 24049221
Diabetes Obes Metab. 2012 Apr;14(4):335-40
pubmed: 22074059
FASEB J. 2012 Aug;26(8):3483-92
pubmed: 22593549
Nat Neurosci. 2016 Jun;19(6):835-44
pubmed: 27135215
Hepatology. 2016 Oct;64(4):1086-104
pubmed: 27387967
Science. 2017 Aug 4;357(6350):503-507
pubmed: 28774929
Cell Metab. 2007 Jun;5(6):438-49
pubmed: 17550779
Nat Commun. 2015 Sep 18;6:8237
pubmed: 26381935
Diabetes Care. 2010 Jul;33(7):1503-8
pubmed: 20332352
Am J Physiol. 1996 Feb;270(2 Pt 2):R315-8
pubmed: 8779860
Neuropsychopharmacology. 2015 Aug;40(9):2085-95
pubmed: 25735756
Mol Metab. 2015 Oct 22;4(12):961-70
pubmed: 26909312
Nat Rev Endocrinol. 2015 Aug;11(8):489-501
pubmed: 26122319
Hippocampus. 2015 Jul;25(7):858-75
pubmed: 25545461
Lancet. 2001 Feb 3;357(9253):354-7
pubmed: 11210998
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10085-90
pubmed: 12897241
Gastroenterology. 2013 Mar;144(3):636-649.e6
pubmed: 23142626
N Engl J Med. 1994 Oct 6;331(14):904-9
pubmed: 7915824
Diabetes Obes Metab. 2010 Dec;12(12):1048-57
pubmed: 20977575
Endocrinology. 2003 Feb;144(2):544-51
pubmed: 12538615
Obesity (Silver Spring). 2011 Jul;19(7):1439-44
pubmed: 21394093
Diabetol Metab Syndr. 2015 Nov 14;7:99
pubmed: 26583049
Lancet. 2016 May 7;387(10031):1947-56
pubmed: 26868660
Q J Exp Psychol A. 1991 Nov;43(4):907-12
pubmed: 1775668
Nutr Res Rev. 2014 Jun;27(1):63-93
pubmed: 24872083
Cell Metab. 2016 Jul 12;24(1):31-40
pubmed: 27292605
Pharmacol Biochem Behav. 1987 Jul;27(3):399-405
pubmed: 2889218
Eur J Neurosci. 2005 Jun;21(11):2993-3001
pubmed: 15978010
Cell Rep. 2016 Aug 23;16(8):2231-2242
pubmed: 27524625
J Clin Endocrinol Metab. 2011 Feb;96(2):273-88
pubmed: 21296991
Diabetes Care. 2000 Aug;23(8):1154-61
pubmed: 10937514
Cell Metab. 2011 Oct 5;14(4):478-90
pubmed: 21982708
J Surg Res. 2008 Jan;144(1):158-70
pubmed: 17936790
Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1859-63
pubmed: 1825729
Nature. 1981 Nov 26;294(5839):366-8
pubmed: 6273735
Trends Neurosci. 2007 Aug;30(8):375-81
pubmed: 17604133
Mol Metab. 2016 Feb 10;5(4):271-282
pubmed: 27069867
Nat Neurosci. 2002 Aug;5(8):727-8
pubmed: 12101402
Cell Rep. 2014 Oct 9;9(1):366-377
pubmed: 25284795
Nat Med. 2010 Sep;16(9):1001-8
pubmed: 20802499
Clin Biochem. 2002 Jun;35(4):315-20
pubmed: 12135695
Cell Rep. 2016 Apr 26;15(4):735-747
pubmed: 27149844
Cell Metab. 2008 Dec;8(6):459-67
pubmed: 19041762
Int J Eat Disord. 1994 Apr;15(3):205-17
pubmed: 8199600
Nat Neurosci. 2010 May;13(5):635-41
pubmed: 20348917
Brain Res Bull. 1988 Oct;21(4):571-4
pubmed: 3208144
Diabetes Care. 1996 Jun;19(6):667-70
pubmed: 8725871
Proc Natl Acad Sci U S A. 1992 May 1;89(9):3721-5
pubmed: 1315035
Diabetes. 2016 Feb;65(2):421-32
pubmed: 26566631
Front Endocrinol (Lausanne). 2019 Jan 22;9:768
pubmed: 30740089
Nat Neurosci. 2016 Oct;19(10):1341-7
pubmed: 27548245
Diabetes. 2014 Oct;63(10):3346-58
pubmed: 24917578
Am J Physiol. 1997 Jun;272(6 Pt 2):R1925-30
pubmed: 9227609
Endocrinology. 2013 Oct;154(10):3589-98
pubmed: 23861376
Cell Metab. 2017 Feb 7;25(2):312-321
pubmed: 28041956
Neuroendocrinology. 2017;104(2):145-156
pubmed: 27002827
J Clin Endocrinol Metab. 2010 Oct;95(10):4720-8
pubmed: 20631025
J Clin Invest. 2007 Nov;117(11):3475-88
pubmed: 17885689
Nat Rev Endocrinol. 2016 Jul;12(7):421-32
pubmed: 27199291

Auteurs

Cintia Folgueira (C)

Grupo Fisiopatología Endocrina, Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo. Hospitalario Universitario de Santiago (CHUS/SERGAS), Instituto de Investigación Sanitaria, Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Daniel Beiroa (D)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Begoña Porteiro (B)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Manon Duquenne (M)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm UMR-S 1172, Lille, France.

Emma Puighermanal (E)

IGF, Inserm, CNRS, Univ. Montpellier, F-34094 Montpellier, France.

Marcos F Fondevila (MF)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Silvia Barja-Fernández (S)

Grupo Fisiopatología Endocrina, Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo. Hospitalario Universitario de Santiago (CHUS/SERGAS), Instituto de Investigación Sanitaria, Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Rosalia Gallego (R)

Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela, S. Francisco s/n, 15782 Santiago de Compostela (A Coruña), Spain.

René Hernández-Bautista (R)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.

Cecilia Castelao (C)

Grupo Fisiopatología Endocrina, Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo. Hospitalario Universitario de Santiago (CHUS/SERGAS), Instituto de Investigación Sanitaria, Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Ana Senra (A)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.

Patricia Seoane (P)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Noemi Gómez (N)

Molecular Imaging Group, Department of Psychiatry, Radiology and Public Health, Faculty of Medicine Universidade de Santiago de Compostela (USC), Santiago de Compostela 15782 Spain; Molecular Imaging Group. Health Research Institute of Santiago de Compostela (IDIS). Travesía da Choupana s/n Santiago de Compostela. Zip Code: 15706. Spain; Nuclear Medicine Department University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n. Santiago de Compostela 15706 Spain.

Pablo Aguiar (P)

Molecular Imaging Group, Department of Psychiatry, Radiology and Public Health, Faculty of Medicine Universidade de Santiago de Compostela (USC), Santiago de Compostela 15782 Spain; Molecular Imaging Group. Health Research Institute of Santiago de Compostela (IDIS). Travesía da Choupana s/n Santiago de Compostela. Zip Code: 15706. Spain; Nuclear Medicine Department University Clinical Hospital Santiago de Compostela (SERGAS) (CHUS), Travesía Choupana s/n. Santiago de Compostela 15706 Spain.

Diana Guallar (D)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.

Miguel Fidalgo (M)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.

Amparo Romero-Pico (A)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Roger Adan (R)

Brain Center Rudolf Magnus, Department of Neuroscience and Pharmacology, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands.

Clemence Blouet (C)

MRC Metabolic Disease Unit. Institute of Metabolic Science. University of Cambridge, UK.

Jose Luís Labandeira-García (JL)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
Networking Research Center on Neurodegenerative Diseases, CIBERNED, Madrid, Spain.

Françoise Jeanrenaud (F)

Laboratory of Metabolism, Division of Endocrinology, Diabetology and Nutrition, Department of Internal Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Imre Kallo (I)

Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, HAS, 1083, Budapest, Hungary.

Zsolt Liposits (Z)

Laboratory of Endocrine Neurobiology, Institute of Experimental Medicine, HAS, 1083, Budapest, Hungary.

Javier Salvador (J)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.
Department of Endocrinology & Nutrition, Clínica Universidad de Navarra & IdiSNA, Pamplona, Spain.

Vincent Prevot (V)

Jean-Pierre Aubert Research Center (JPArc), Laboratory of Development and Plasticity of the Neuroendocrine Brain, Inserm UMR-S 1172, Lille, France.

Carlos Dieguez (C)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Miguel Lopez (M)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Emmanuel Valjent (E)

IGF, Inserm, CNRS, Univ. Montpellier, F-34094 Montpellier, France.

Gema Frühbeck (G)

CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.
Department of Endocrinology & Nutrition, Clínica Universidad de Navarra & IdiSNA, Pamplona, Spain.

Luisa M Seoane (LM)

Grupo Fisiopatología Endocrina, Instituto de Investigación Sanitaria de Santiago de Compostela, Complexo. Hospitalario Universitario de Santiago (CHUS/SERGAS), Instituto de Investigación Sanitaria, Santiago de Compostela, Travesía da Choupana s/n, 15706 Santiago de Compostela, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Ruben Nogueiras (R)

CIMUS, Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, 15782, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), 15706, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH